Correlation Between Cigna Corp and Neogen
Can any of the company-specific risk be diversified away by investing in both Cigna Corp and Neogen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cigna Corp and Neogen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cigna Corp and Neogen, you can compare the effects of market volatilities on Cigna Corp and Neogen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cigna Corp with a short position of Neogen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cigna Corp and Neogen.
Diversification Opportunities for Cigna Corp and Neogen
0.74 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Cigna and Neogen is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Cigna Corp and Neogen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neogen and Cigna Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cigna Corp are associated (or correlated) with Neogen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neogen has no effect on the direction of Cigna Corp i.e., Cigna Corp and Neogen go up and down completely randomly.
Pair Corralation between Cigna Corp and Neogen
Allowing for the 90-day total investment horizon Cigna Corp is expected to generate 0.71 times more return on investment than Neogen. However, Cigna Corp is 1.4 times less risky than Neogen. It trades about -0.14 of its potential returns per unit of risk. Neogen is currently generating about -0.15 per unit of risk. If you would invest 34,355 in Cigna Corp on September 26, 2024 and sell it today you would lose (6,349) from holding Cigna Corp or give up 18.48% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Cigna Corp vs. Neogen
Performance |
Timeline |
Cigna Corp |
Neogen |
Cigna Corp and Neogen Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cigna Corp and Neogen
The main advantage of trading using opposite Cigna Corp and Neogen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cigna Corp position performs unexpectedly, Neogen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neogen will offset losses from the drop in Neogen's long position.Cigna Corp vs. Definitive Healthcare Corp | Cigna Corp vs. Edwards Lifesciences Corp | Cigna Corp vs. Outset Medical | Cigna Corp vs. Doximity |
Neogen vs. Cigna Corp | Neogen vs. Definitive Healthcare Corp | Neogen vs. Guardant Health | Neogen vs. Laboratory of |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |